Rare but serious risks (like pancreatitis) will be discussed by your provider
The trial program has evolved from glycemic-safety and outcomes studies in T2D (the LEADER, SUSTAIN-6, REWIND, EXSCEL, and PIONEER 6 era [10][13], [19]), to outcomes trials in expanded populations including obesity without diabetes (SELECT [3]), HFpEF with obesity (SUMMIT [5], with a companion semaglutide program in STEP-HFpEF [20], [21]), CKD (FLOW [22]), and an active-comparator setting (SURPASS-CVOT [6])
A Head-to-Head Comparison of Weight Loss Efficacy When you dive into the research, it becomes clear that while both tirzepatide and semaglutide are transformative for weight loss, one consistently shows higher average results
2014 May 1
Naturalmente, queste sono solo linee guida informative, piuttosto prima di assumere supplementi di tale genere sarebbe bene consultare uno specialista del settore che possa decidere il cammino pi opportuno